Kiora Pharmaceuticals, Inc. (KPRX)

NASDAQ: KPRX · Real-Time Price · USD

1.230

-0.100 (-7.52%)

At close: Nov 13, 2026, 4:00 PM EST

1.250

+0.020 (1.63%)

After-hours: Nov 13, 2026, 4:25 PM EST

Kiora Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.57	8.7	3.79	2.45	5.96	7.85
Short-Term Investments	10.72	8.39	23	-	-	-
Cash & Short-Term Investments	16.29	17.09	26.79	2.45	5.96	7.85
Cash Growth	-15.94%	-36.22%	991.47%	-58.85%	-24.06%	562.47%
Accounts Receivable	0.64	1.52	0.6	-	-	-
Other Receivables	1.58	1.79	0.27	2.05	1.37	0.53
Receivables	2.22	3.32	0.87	2.05	1.37	0.53
Prepaid Expenses	1.41	1.34	2.04	0.23	0.34	0.61
Total Current Assets	19.91	21.75	29.71	4.74	7.68	8.99
Property, Plant & Equipment	0.31	0.38	0.06	0.11	0.17	0.28
Other Intangible Assets	2.06	-	-	0.12	0.14	0.17
Long-Term Deferred Charges	-	2.06	6.69	8.7	10.6	10.6
Other Long-Term Assets	0.09	0.06	0.03	0.05	0.08	0.09
Total Assets	22.37	24.25	36.48	13.71	18.68	20.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.21	1.06	0.42	0.21	1.01	0.16
Accrued Expenses	2.15	2.26	2.26	1.38	1.84	1.33
Current Portion of Leases	0.16	0.16	0.02	0.05	0.11	0.12
Current Income Taxes Payable	-	0.14	2.33	-	-	-
Other Current Liabilities	-	-	0.98	-	0.32	-
Total Current Liabilities	2.52	3.63	6.01	1.63	3.27	1.61
Long-Term Leases	0.12	0.2	0.03	0.06	-	0.09
Long-Term Unearned Revenue	1.25	1.25	-	-	-	-
Long-Term Deferred Tax Liabilities	0.1	0.1	0.49	0.78	0.69	0.8
Other Long-Term Liabilities	3.08	2.94	4.19	5.13	3.31	3.05
Total Liabilities	7.08	8.13	10.72	7.6	7.27	5.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.28	0.28	0.27	0.08	0.02	0
Additional Paid-In Capital	175.72	170.31	169.16	153.19	146.04	135.54
Retained Earnings	-160.46	-154.22	-143.38	-146.98	-134.46	-120.88
Comprehensive Income & Other	-0.25	-0.25	-0.28	-0.18	-0.18	-0.09
Total Common Equity	15.3	16.13	25.76	6.11	11.41	14.58
Shareholders' Equity	15.3	16.13	25.76	6.11	11.41	14.58
Total Liabilities & Equity	22.37	24.25	36.48	13.71	18.68	20.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.29	0.37	0.06	0.11	0.11	0.21
Net Cash (Debt)	16	16.72	26.73	2.35	5.86	7.65
Net Cash Growth	-15.66%	-37.46%	1038.72%	-59.93%	-23.37%	1150.70%
Net Cash Per Share	3.07	4.01	6.48	4.36	72.00	285.39
Filing Date Shares Outstanding	4.42	3.95	3	2.92	0.21	0.04
Total Common Shares Outstanding	4.42	3.76	3	0.86	0.2	0.04
Working Capital	17.4	18.12	23.7	3.1	4.41	7.38
Book Value Per Share	3.46	4.29	8.58	7.14	57.15	414.44
Tangible Book Value	13.23	16.13	25.76	5.99	11.26	14.41
Tangible Book Value Per Share	2.99	4.29	8.58	7.00	56.43	409.64
Machinery	-	0.01	0.01	0.01	0.15	0.16
Leasehold Improvements	-	0.11	-	-	0.02	0.02

SEC Filings: 10-K · 10-Q